Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 480

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1B
Chunk 480
---
20

On December 28, 2023, the Company issued 176
shares of common stock to Red Chip as deferred equity compensation valued in the amount of $40,000 based on the 30-day average price
of the publicly traded common shares after the IPO, as required by the terms of the investment relations consulting agreement signed
in March 2023.

On January 29, 2024, the Company, entered into
an Underwriting Agreement with WallachBeth Capital LLC, relating to the Company’s public offering (the “January 2024 Offering”)
of 87,682 units at an offering price of $23.10 per unit and 16,652 pre-funded units at an offering price of $22.50 per pre-funded unit.
Each unit consisted of one share of common stock and one warrant exercisable for one share of common stock (the “January 2024 Warrants”).
Each pre-funded unit consists of one pre-funded warrant exercisable for one share of common stock (the “January 2024 Pre-Funded
Warrants”) and one warrant identical to the January 2024 Warrants included in the units. The January 2024 Pre-Funded Warrants have
an exercise price of $0.60 per share, were immediately exercisable beginning on January 31, 2024 until exercised in full. The January
2024 Warrants have an exercise price of $25.41 per share and are exercisable beginning on January 31, 2024 until January 31, 2029. 

The Company granted WallachBeth Capital LLC a
45-day over-allotment option to purchase up to 13,153 shares of the Company’s common stock at a price of $23.10 per share and/or
15,650 January 2024 Warrants at a price of $0.60 per warrant and/or 2,498 January 2024 Pre-Funded Warrants at a price of $22.50 per pre-funded
warrant, or any combination thereof, in all cases less the underwriting discount. WallachBeth Capital LLC partially exercised its over-allotment
option with respect to 13,637 January 2024 Warrants on January 31, 2024, and purchased an additional one share of common stock at a purchase
price of $22.50 per share and one January 2024 Warrant at a purchase price of $0.60 per warrant on February 14, 2024.